"Unequivocally abnormal" vs "usual" signs and symptoms for proficient diagnosis of diabetic polyneuropathy: Cl vs N Phys trial

Archives of Neurology

Volumn 69, Issue 12, 2012, Pages 1609-1614

  Dyck, Peter J ^a   Overland, Carol J ^a   Low, Phillip A ^a   Litchy, William J ^a   Davies, Jenny L ^a   Dyck, P James B ^a   Carter, Rickey E ^a   Melton III, L Joseph ^a   Andersen, Henning ^b   Albers, James W ^c   Bolton, Charles F ^d   England, John D ^e   Klein, Christopher J ^a   Llewelyn, Gareth ^f   Mauermann, Michelle L ^a   Russell, James W ^g   Selvarajah, Dinesh ⁱ   Singer, Wolfgang ^a   Smith, A Gordon ^h   Tesfaye, Solomon ⁱ   Vella, Adrian ^a   more..

^a MAYO CLINIC   (United States)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF MICHIGAN   (United States)

^d QUEEN S UNIVERSITY   (Canada)

^e LOUISIANA STATE UNIVERSITY   (United States)

^f UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^g UNIVERSITY OF MARYLAND   (United States)

^h UNIVERSITY OF UTAH   (United States)

ⁱ SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; AGE; ARTICLE; CLINICAL ARTICLE; CLINICAL DECISION MAKING; CLINICAL FEATURE; COMPARATIVE STUDY; DIABETIC NEUROPATHY; DIABETIC SENSORIMOTOR POLYNEUROPATHY; DIAGNOSTIC VALUE; GENDER; HUMAN; HYPOREFLEXIA; NERVE CONDUCTION DISORDER; NEUROLOGIST; NEUROMUSCULAR PHYSICIAN; NEUROPHYSIOLOGY; PINPRICK SENSATION; PRESSURE SENSATION; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; REPRODUCIBILITY; SENSORIMOTOR NEUROPATHY; SKIN SENSATION; STANDARD; SYMPTOMATOLOGY; TOUCH;

EID: 84871246506     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2012.1481     Document Type: Article

References (18)

1. Gilliatt RW. Clinical aspects of diabetic neuropathy. In: Cumings JN, Kremer M, eds. Biochemical Aspects of Neurological Disorders. Oxford, England: Blackwell; 1965:117-142.
2. Pirart J. Diabetic neuropathy: ametabolic or a vascular disease? Diabetes. 1965;14:1-9.
3. Nilsson SV, Nilsson JE, Frostberg N, Emilsson T. The Kristianstad survey, II: studies in a representative adult diabetic population with special reference to comparison with an adequate control group. Acta Med Scand Suppl. 1967;469:1-42.
4. Franklin GM, Kahn LB, Baxter J, Marshall JA, Hamman RF. Sensory neuropathy in non-insulin-dependent diabetes mellitus: the San Luis Valley Diabetes Study. Am J Epidemiol. 1990;131(4):633-643. (Pubitemid 20137231)
5. England JD, Gronseth GS, Franklin G, et al American Academy of Neurology; American Association of Electrodiagnostic Medicine; American Academy of Physical Medicine and Rehabilitation. Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology. 2005;64(2):199-207.
6. Dyck PJ, Kratz KM, Lehman KA, et al. The Rochester 54 Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology. 1991;41(6):799-807.
7. Dyck PJ, Overland CJ, Low PA, et al; Cl vs NPhys Trial Investigators. Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs NPhys trial. Muscle Nerve. 2010;42(2):157-164.
8. Report and recommendations of the San Antonio conference on diabetic neuropathy. Neurology. 1988;38(7):1161-1165.
9. Tesfaye S, Boulton AJ, Dyck PJ, et al Toronto Diabetic Neuropathy Expert Group. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33(10):2285-2293.
10. Dyck PJ, Sherman WR, Hallcher LM, et al. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol. 1980;8(6):590-596. (Pubitemid 11213503)
11. Dyck PJ, Carter RE, Litchy WJ. Modeling nerve conduction criteria for diagnosis of diabetic polyneuropathy. Muscle Nerve. 2011;44(3):340-345.
12. Johnston SC, Hauser SL. The beautiful and ethereal neurological exam: an appeal for research. Ann Neurol. 2011;70(2):A9-A10.
13. Mulder DW, Lambert EH, Bastron JA, Sprague RG. The neuropathies associated with diabetes mellitus: a clinical and electromyographic study of 103 unselected diabetic patients. Neurology. 1961;11(4, pt 1):275-284.
14. Albers JW, Herman WH, Pop-Busui R, et al; Diabetes Control and Complications Trial /Epidemiology of Diabetes Interventions and Complications Research Group. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care. 2010;33(5):1090-1096.
15. Dyck PJ, O'Brien PC. Polyneuropathy dysfunction scores. J Neurol Neurosurg Psychiatry. 2006;77(8):899-900. (Pubitemid 44174069)
16. Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993;43(4):817-824. (Pubitemid 23121981)
17. Dyck PJ, Bushek W, Spring EM, et al. Vibratory and cooling detection thresholds compared with other tests in diagnosing and staging diabetic neuropathy. Diabetes Care. 1987;10(4):432-440. (Pubitemid 17133605)
18. Dyck PJ, Hughes RAC, O'Brien PC. Quantitating overall neuropathic symptoms, impairments, and outcomes. In: Dyck PJ, Thomas PK, eds. Peripheral Neuropathy. 4th ed. Philadelphia, PA: Elsevier; 2005:1031-1052.